Humana (HUM) FY2012 results: revenue $39.1 billion, up 6.2% on the year
Humana Inc. (HUM) reported revenue of $39.1 billion for fiscal 2012, the year ended 31 December 2012, up 6.2% on the year before. Net income was $1.2 billion, down 13.9%, and diluted earnings per share $7.47. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2013.
Revenue
$39.1 billion
+6.2% on the year
FY2007FY2012
Operating margin
5.2%
6.4% a year earlier
FY2007FY2012
Net income
$1.2 billion
-13.9% on the year
FY2007FY2012
Diluted EPS
$7.47
-11.7% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
39,126
36,832
33,596
+6.2%
Selling, general and administrative
5,830
5,395
4,380
+8.1%
Operating income
2,016
2,344
1,855
-14.0%
Operating margin
5.2%
6.4%
5.5%
Interest expense
105
109
105
-3.7%
Pre-tax income
1,911
2,235
1,750
-14.5%
Income tax
689
816
650
-15.6%
Effective tax rate
36.1%
36.5%
37.2%
Net income
1,222
1,419
1,099
-13.9%
Net margin
3.1%
3.9%
3.3%
Diluted EPS
$7.47
$8.46
$6.47
-11.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
1,923
2,079
2,242
-7.5%
Capital expenditure
410
346
222
+18.5%
Free cash flow
1,513
1,733
2,019
-12.7%
Free cash flow margin
3.9%
4.7%
6.0%
Cash from investing
-1,965
-1,358
-1,811
Cash from financing
-29.0
-1,017
-371
Depreciation and amortisation
338
303
263
+11.6%
Share-based compensation
82.0
67.0
62.9
+22.4%
Buybacks
518
541
108
-4.3%
Dividends paid
165
82.0
0.0
+101.2%
Dividend per share
$1.03
$0.75
$0.00
+37.3%
Diluted shares, weighted
163m
168m
170m
-2.6%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
8,847
8,063
6,924
+9.7%
Debt
2,935
1,965
2,078
+49.4%
Other liabilities
8,197
7,680
7,101
+6.7%
Total liabilities and equity
19,979
17,708
16,103
+12.8%
Fixed assets
1,098
912
815
+20.4%
Goodwill
3,640
2,740
2,568
+32.8%
Intangible assets
731
435
399
+68.0%
Investments
9,847
9,453
8,372
+4.2%
Cash and equivalents
1,306
1,377
1,673
-5.2%
Receivables
733
1,034
959
-29.1%
Other assets
2,624
1,757
1,316
+49.3%
Total assets
19,979
17,708
16,103
+12.8%
10-K for the year ended 31 December 2012, filed 22 February 2013: the filing.